Quest for the right Drug
סודיום כלוריד 0.9% וגלוקוז 5.0% תמיסה לעירוי בקסטר SODIUM CHLORIDE 0.9 % AND GLUCOSE 5 % SOLUTION FOR INFUSION BAXTER (GLUCOSE AS MONOHYDRATE, SODIUM CHLORIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי : I.V
צורת מינון:
תמיסה לאינפוזיה : SOLUTION FOR INFUSION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects The following adverse reactions have been reported in post-marketing experience, listed by MedDRA System Organ Class (SOC), then where feasible, by Preferred Term in order of severity. Frequencies cannot be estimated from the available data, as all listed adverse reactions are based on spontaneous reporting. Adverse reactions System Organ Class Frequency (Preferred terms) anaphylactic reaction, * Immune system disorders Not known hypersensitivity* hypernatraemia, Metabolism and nutrition hyperglycaemia, Not known disorders hospital acquired hyponatraemia** Nervous system disorders hyponatraemic encephalopathy** Not known 7 of 11 Vascular disorders phlebitis Not known Skin and subcutaneous tissue rash, pruritus Not known disorders injection site reactions including: General disorders and pyrexia administration site chills Not known conditions infusion site pain infusion site vesicles *Potential manifestation in patients with allergy to corn, see section 4.4 ** Hospital acquired hyponatraemia may cause irreversible brain injury and death due to development of acute hyponatraemic encephalopathy (see sections 4.2 and 4.4). Other adverse reactions reported with isotonic saline and glucose infusions include: • Hyponatraemia, which may be symptomatic • Hyperchloraemic acidosis Adverse reactions may be associated to the medicinal product(s) added to the solution; the nature of the additive will determine the likelihood of any other adverse reactions. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form: https://sideeffects.health.gov.il/
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף